A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)
Interventions: DRUG: Capivasertib|DRUG: Itraconazole
Sponsor: AstraZeneca
Collaborators: Parexel